Case #1—Evaluating prognostic tools in early breast cancer

Fellow presenter: Lina Pugliano, MD

Lina Pugliano, MD
Institut Jules Bordet
Brussels, Belgium

Faculty discussant: Christos Sotiriou, MD, PhD

Christos Sotiriou, MD, PhD
Institut Jules Bordet
Brussels, Belgium

Case #2—Challenges in endocrine-responsive metastatic breast cancer: Overcoming resistance to endocrine therapy

Siobhan Lynch, MD
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas, United States

Ana Maria Gonzalez-Angulo, MD, MSc, FACP
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas, United States

Case #3—Inflammatory breast cancer: Treatment strategies in early-stage disease

Costatine Albany, MD
Indiana University
Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States

Kathy Miller, MD
Indiana University
Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States

Case #4—Brain metastases in HER2-positive breast cancer: Challenges and opportunities

Inês Luís, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Nancy Lin, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Case #5—Metastatic triple-negative breast cancer: A dilemma in search of practical solutions

Komal Jhaveri, MD
Memorial Sloan-Kettering Cancer Center
New York, New York, United States

Angelo Di Leo, MD, PhD
Hospital of Prato
Istituto Toscano Tumori
Prato, Italy

Support for this educational activity is provided by the Breast Cancer Research Foundation and the European School of Oncology.